PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV)
CUSIP: 72941H509
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 179,252,507
- Total 13F shares
- 5,214,831
- Share change
- +4,836,621
- Total reported value
- $3,565,788
- Price per share
- $0.68
- Number of holders
- 23
- Value change
- +$3,367,892
- Number of buys
- 19
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 72941H509?
CUSIP 72941H509 identifies PSTV - PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 72941H509:
Top shareholders of PSTV - PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| S.H.N. Financial Investments Ltd. |
13D/G
|
— |
1.5%
|
1,500,000
|
$525,000 | +$101,586 | 14 Aug 2025 | |
| Orin Hirschman |
13D/G
|
— |
3.9%
|
1,283,681
|
$410,778 | +$231,288 | 30 Jun 2025 | |
| Robert P. Lenk |
3/4/5
|
Director |
—
mixed-class rows
|
437,121
mixed-class rows
|
$68,116 | +$53,779 | 22 Aug 2025 | |
| Greg Petersen |
3/4/5
|
Director |
—
mixed-class rows
|
113,553
mixed-class rows
|
$66,043 | — | 18 Feb 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.07%
|
117,454
|
$40,851 | — | 30 Jun 2025 | |
| Howard Clowes |
3/4/5
|
Director |
—
mixed-class rows
|
324,291
mixed-class rows
|
$35,405 | — | 13 Aug 2025 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
87,638
|
$30,498 | — | 30 Jun 2025 | |
| Richard J. Hawkins |
3/4/5
|
Director |
—
mixed-class rows
|
412,982
mixed-class rows
|
$22,767 | — | 13 Aug 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
51,176
|
$17,798 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.02%
|
32,541
|
$11,324 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
26,753
|
$9,305 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
24,233
|
$8,428 | — | 30 Jun 2025 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.01%
|
11,453
|
$3,983 | — | 30 Jun 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
10,223
|
$3,556 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
6,960
|
$2,421 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
6,045
|
$2,102 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
2,258
|
$785 | — | 30 Jun 2025 | |
| Atlantic Union Bankshares Corp |
13F
|
Company |
0%
|
500
|
$174 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
357
|
$124 | — | 30 Jun 2025 | |
| Tradewinds Capital Management, LLC |
13F
|
Company |
0%
|
200
|
$70 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
158
|
$55 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
133
|
$45 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
102
|
$36 | — | 30 Jun 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
26
|
$8 | — | 30 Jun 2025 | |
| An van Es-Johansson |
3/4/5
|
Director |
—
class O/S missing
|
297,794
|
— | — | 13 Aug 2025 | |
| Kyle Guse |
3/4/5
|
Director |
—
class O/S missing
|
40,000
|
— | — | 13 Aug 2025 | |
| Norman D. LaFrance |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
24,073
|
— | — | 22 Feb 2024 |
Institutional Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) as of Q3 2025
As of 30 Sep 2025,
PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,214,831 shares.
The largest 10 holders included
VANGUARD GROUP INC, Altium Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, BlackRock, Inc., STATE STREET CORP, NORTHERN TRUST CORP, Scientech Research LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and MERCER GLOBAL ADVISORS INC /ADV.
This page lists
23
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
17
Q3 2025 holders
23
Holder diff
6
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.